DDAIP: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:DDAIP}} | |||
== Overview == | == Overview == | ||
'''DDAIP''' (Dodecyl 2-(N,N-dimethylamino)propionate) is a chemical compound used primarily as a [[penetration enhancer]] in [[topical drug delivery]] systems. It is known for its ability to increase the permeability of the [[stratum corneum]], the outermost layer of the [[skin]], thereby facilitating the absorption of active pharmaceutical ingredients. | |||
== Chemical Structure == | |||
[[File:DDAIP.svg|thumb|right|Chemical structure of DDAIP]] | |||
DDAIP is an ester of dodecyl alcohol and 2-(N,N-dimethylamino)propionic acid. Its molecular structure consists of a long hydrophobic alkyl chain and a hydrophilic ester group, which contribute to its amphiphilic properties. This dual nature allows DDAIP to interact with both lipophilic and hydrophilic environments, making it an effective penetration enhancer. | |||
== Mechanism of Action == | == Mechanism of Action == | ||
DDAIP enhances drug delivery by disrupting the lipid bilayers of the stratum corneum. This disruption increases the fluidity of the lipid matrix, allowing for greater diffusion of drugs through the skin. Additionally, DDAIP may interact with keratin proteins, further facilitating the penetration of active compounds. | |||
== Applications == | == Applications == | ||
DDAIP is used in various [[pharmaceutical formulations]] to improve the bioavailability of drugs administered via the skin. It is particularly useful in formulations where rapid onset of action is desired, such as in [[transdermal patches]] and [[topical creams]]. | |||
DDAIP | |||
== Safety and Efficacy == | == Safety and Efficacy == | ||
The safety profile of DDAIP has been evaluated in several studies, indicating that it is generally well-tolerated when used in appropriate concentrations. However, as with any penetration enhancer, there is a potential for irritation or allergic reactions, and its use should be carefully monitored. | |||
== Related Pages == | |||
* [[Penetration enhancer]] | |||
== | * [[Topical drug delivery]] | ||
* [[Stratum corneum]] | |||
* [[ | * [[Transdermal patch]] | ||
* [[ | |||
* [[ | |||
[[Category: | [[Category:Pharmaceuticals]] | ||
[[Category: | [[Category:Chemical compounds]] | ||
Latest revision as of 03:26, 13 February 2025
Overview[edit]
DDAIP (Dodecyl 2-(N,N-dimethylamino)propionate) is a chemical compound used primarily as a penetration enhancer in topical drug delivery systems. It is known for its ability to increase the permeability of the stratum corneum, the outermost layer of the skin, thereby facilitating the absorption of active pharmaceutical ingredients.
Chemical Structure[edit]
DDAIP is an ester of dodecyl alcohol and 2-(N,N-dimethylamino)propionic acid. Its molecular structure consists of a long hydrophobic alkyl chain and a hydrophilic ester group, which contribute to its amphiphilic properties. This dual nature allows DDAIP to interact with both lipophilic and hydrophilic environments, making it an effective penetration enhancer.
Mechanism of Action[edit]
DDAIP enhances drug delivery by disrupting the lipid bilayers of the stratum corneum. This disruption increases the fluidity of the lipid matrix, allowing for greater diffusion of drugs through the skin. Additionally, DDAIP may interact with keratin proteins, further facilitating the penetration of active compounds.
Applications[edit]
DDAIP is used in various pharmaceutical formulations to improve the bioavailability of drugs administered via the skin. It is particularly useful in formulations where rapid onset of action is desired, such as in transdermal patches and topical creams.
Safety and Efficacy[edit]
The safety profile of DDAIP has been evaluated in several studies, indicating that it is generally well-tolerated when used in appropriate concentrations. However, as with any penetration enhancer, there is a potential for irritation or allergic reactions, and its use should be carefully monitored.
